Interestingly, breast cancer and SSc share select molecular pathways, including hyperactivation of the mammalian target of rapamycin (mTOR), phosphatidylinositol 3-kinase (PI3K), and transforming growth factor beta (TGF-β) (145). This evidence concerns the gene MTOR and breast carcinoma.